tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ARQT is currently covered by 6 analysts with an average price target of $41.61. This is a potential upside of $15.88 (61.72%) from yesterday's end of day stock price of $25.73.
Arcutis Biotherapeutics 's activity chart (see below) currently has 104 price targets and 89 ratings on display. The stock rating distribution of ARQT is 85.71% BUY and 14.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 39.15% with an average time for these price targets to be met of 98.87 days.
Highest price target for ARQT is $37, Lowest price target is $15, average price target is $21.6.
Most recent stock forecast was given by UY EAR from MIZUHO on 28-Nov-2025. First documented stock forecast 25-Feb-2020.
Currently out of the existing stock ratings of ARQT, 12 are a BUY (85.71%), 2 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Jan-2024
$37
$10.8 (41.22%)
$21
2 months 2 days ago
(28-Nov-2025)
7/19 (36.84%)
$6.04 (19.51%)
269
Buy Since 07-Sep-2022
$22
$-4.2 (-16.03%)
$20
5 months 23 days ago
(07-Aug-2025)
19/21 (90.48%)
$7.88 (55.81%)
443
Buy Since 30-Dec-2024
$19
$-7.2 (-27.48%)
$19
9 months 27 days ago
(03-Apr-2025)
4/4 (100%)
$2.84 (17.57%)
234
Buy Since 25-Feb-2020
9 months 27 days ago
(03-Apr-2025)
1/1 (100%)
$9.67 (36.73%)
27
Hold Since 13-Oct-2023
$15
$-11.2 (-42.75%)
$11
11 months 3 days ago
(27-Feb-2025)
3/5 (60%)
$2.2 (17.19%)
41
What is ARQT (Arcutis Biotherapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics ) with a proven track record?
Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics )?
Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics )?
Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics )?
